Skip to main content
. 2017 Jun 30;12(6):e0180509. doi: 10.1371/journal.pone.0180509

Fig 3. Dysplastic mucosa at CLE with heptapeptide (VRPMPLQ).

Fig 3

A series of VRPMPLQ/CLE images from different patients showing dysplastic colonocytes.The active binding of the peptide to the colonocytes is observed and determinates a strong increase in fluorescence.